I say this having not looked at the code or maths involved. So I might change me mind in the future.
But! Never say never! Life is scattered with breakthroughs from singletons or small teams that develop an edge. Any follower of F1 will know that.
Sure big business likes to use its budget & team numbers as a weapon of deterrence, to put others off from competing. And whilst they appear to have made substantial gains, its still just average in the scheme of things.
Some examples of wildcards and underdogs beating the best Frontier models:
Goran Ivanišević (2001 Wimbledon)
The 2010-11 Green Bay Packers (Super Bowl XLV)
Greece National Football Team (Euro 2004)
Netflix vs. Blockbuster
The Blair Witch Project
Skype vs. Telecom Giants
Barry Marshall and Robin Warren (Peptic Ulcers)
Kary Mullis (PCR - Polymerase Chain Reaction)
Jennifer Doudna and Emmanuelle Charpentier (CRISPR-Cas9)
Gregor Mendel (Genetics)
The Crispr-Cas9 would perhaps be the most relevant to Ai models.
- The Status Quo: Gene editing was a field dominated by giant, heavily bankrolled genomic centers, utilizing expensive and clunky protein-based tools like zinc fingers.
- The Wild Card: A small, collaborative team led by Doudna and Charpentier (who started her work on a shoestring budget in Europe) zeroed in on a defense mechanism used by bacteria. They figured out how to harness this into a programmable, incredibly cheap, and accessible gene-editing tool. Their wild-card discovery completely eclipsed the older, better-funded methods and won the 2020 Nobel Prize in Chemistry.
So sure these well funded Ai teams might currently have Frontier models, how long until the become eclipsed?